Association between Gut Microbiota Compositions with Microvascular Complications in Individuals with Diabetes: A Systematic Review
- Authors: Hasani M.1, Asadi Pilerud Z.2,3, Kami A.4, Abbas Vaezi A.5, Sobhani S.6, Ejtahed H.7,8, Qorbani M.6,9
-
Affiliations:
- Department of Nutrition, School of Health, Golestan University of Medical Sciences, Gorgan, Iran
- Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran
- Golestan University of Medical Sciences, Gorgan, Iran
- Department of Internal Medicine, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
- Noncommunicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
- Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
- Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
- Issue: Vol 20, No 10 (2024)
- Section: Medicine
- URL: https://snv63.ru/1573-3998/article/view/642958
- DOI: https://doi.org/10.2174/0115733998280396231212114345
- ID: 642958
Cite item
Full Text
Abstract
Background::Diabetes is one of the chronic and very complex diseases that can lead to microvascular complications. Recent evidence demonstrates that dysbiosis of the microbiota composition might result in low-grade, local, and systemic inflammation, which contributes directly to the development of diabetes mellitus and its microvascular consequences.
Objective::The aim of this systematic review was to investigate the association between diabetes microvascular complications, including retinopathy, neuropathy, nephropathy, and gut microbiota composition.
Methods::A systematic search was carried out in PubMed, Scopus, and ISI Web of Science from database inception to March 2023. Screening, data extraction, and quality assessment were performed by two independent authors. The Newcastle-Ottawa Quality Assessment Scale was used for quality assessment.
Results::About 19 articles were selected from 590 retrieved articles. Among the included studies, nephropathy has been studied more than other complications of diabetes, showing that the composition of the healthy microbiota is changed, and large quantities of uremic solutes that cause kidney injury are produced by gut microbes. Phyla, including Fusobacteria and Proteobacteria, accounted for the majority of the variation in gut microbiota between Type 2 diabetic patients with and without neuropathy. In cases with retinopathy, an increase in pathogenic and proinflammatory bacteria was observed.
Conclusion::Conclusion: Our results revealed that increases in Bacteroidetes, Proteobacteria and Fusobacteria may be associated with the pathogenesis of diabetic nephropathy, neuropathy, and retinopathy.
:In view of the detrimental role of intestinal dysbiosis in the development of diabetes-related complications, gut microbiota assessment may be used as a biomarker in the future and interventions that modulate the composition of microbiota in individuals with diabetes can be used to prevent and control these complications.
About the authors
Motahareh Hasani
Department of Nutrition, School of Health, Golestan University of Medical Sciences, Gorgan, Iran
Author for correspondence.
Email: info@benthamscience.net
Zahra Asadi Pilerud
Student ResearchCommittee, Alborz University of Medical Sciences, Karaj, Iran;
Email: info@benthamscience.net
Atefe Kami
Golestan University of Medical Sciences, Gorgan,Iran
Email: info@benthamscience.net
Amir Abbas Vaezi
Department of Internal Medicine, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
Author for correspondence.
Email: info@benthamscience.net
Sahar Sobhani
NoncommunicableDiseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
Email: info@benthamscience.net
Hanieh-Sadat Ejtahed
Obesity and Eating HabitsResearch Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences,
Tehran, Iran; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute,
Tehran University of Medical Sciences, Tehran, Iran
Email: info@benthamscience.net
Mostafa Qorbani
NoncommunicableDiseases Research Center, Alborz University of Medical Sciences, Karaj, Iran; Chronic Diseases Research Center, Endocrinology and Metabolism
Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Email: info@benthamscience.net
Supplementary files
